SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas strategic equity investment and clinical-trial collaboration with Summit around ivonescimab are driving attention, with traders welcoming the added financing and major-pharma backing. Some speculate the stake could lead to an acquisition, while others stress that the deal is not a buyout and does not remove the pending FDA decision risk.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for a U.S. Army program to develop ultra-high-voltage silicon-carbide technology is drawing attention as a validation of its capabilities and a potential defense-market opportunity. Traders are divided between seeing the award as a longer-term catalyst and noting that it is a prototype project with undisclosed financial terms, while short-squeeze hopes compete with concerns that the initial pop may fade.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoins sharp breakout rally and subsequent pullback are driving attention, with traders debating whether the consolidation will lead to further gains or whether the move will fade like previous pumps. Bulls point to improving price action, while skeptics cite weak follow-through and the coins history of giving back gains.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks Phase 3 DAYBREAK study met its primary goals in wet AMD, with Zenkuda showing potential for six-month dosing intervals and the company planning an FDA filing. Traders celebrated the results and the sharp rally, while others questioned the valuation and warned that financing needs, possible dilution and profit-taking could weigh on the shares.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing shares are under pressure after the FAA delayed 737 MAX 10 certification while reviewing a flight-management software issue that can disrupt automated guidance in a specific landing scenario. Traders are divided: critics see another quality-control and certification setback, while bullish voices call the issue manageable and the selloff an overreaction.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Rising Treasury yields, oil-market pressure and uncertainty around Iran are weighing on the S&P 500, while traders also point to weak market breadth and concerns about AI-heavy leadership. The discussion is split between bears warning of a deeper pullback and bulls looking for a rebound, with many describing choppy, headline-driven trading.

Select Sector SPDR Trust (The) - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

Technology-sector leadership and momentum are driving attention, with traders watching for a breakout amid AI, semiconductor, and mega-cap earnings and capex themes. The community is divided between seeing tech as a market leader and warning that narrow breadth and a pullback could prompt rotation into other sectors.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Anticipation around NASAs CLPS 2.0 contract awards is the dominant topic, with traders watching for an announcement after repeated schedule delays and speculating about Intuitive Machines potential share of the awards. The uncertainty is fueling bullish hopes for a contract-driven rebound alongside frustration over delays and the stocks volatile, weak price action.

Select Sector SPDR Trust (The) - State Street Health Care Select Sector SPDR ETF

Health Care Select Sector SPDR Fund

Healthcares relative strength and rotation into defensive exposure, often contrasted with weakness in technology and semiconductors, dominate the discussion. Traders cite XLVs bullish technical structure, while some remain cautious about pullbacks or whether the sectors outperformance will persist.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FHFAs move to let Fannie Mae and Freddie Mac accept VantageScore alongside FICO has intensified concerns that competition could weaken FICOs long-standing mortgage-scoring position, with traders also debating scrutiny of its pricing. The selloff has prompted some to call the shares a buying opportunity, while others see a lasting threat to the companys moat and question its valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Attention is centered on speculation that an Anthropic IPO could boost VCX, which holds stakes in private AI companies. Traders are also debating whether IPO-related buying and short covering can offset selling pressure after the share lockup expired and concerns that VCX trades at a premium to its underlying value.

‘Pharma Bro’ Martin Shkreli Slams Anthropic’s Claude Drug-Discovery Claims: ‘This Is Not Impressive Work’

Equity

Claude-designed proteins successfully bound to 14 of 15 targets in independent testing by Adaptyv Bio and Twist Bioscience. 

Anthropic, OpenAI Said To Be Racing For Public Markets: Reports Of Pre-IPO Moves Tell Very Different Stories

Anthropic is reportedly meeting investors for its IPO and could launch the share sale as early as next month. OpenAI has reportedly deferred its plans to next year. 


Dan Ives Says American AI Tech Is Far Superior To China’s: ‘No One Will Compare From A Model Perspective’

While the launch of Moonshot AI’s Kimi K3 was a “mini DeepSeek moment,” the reality is that OpenAI and Anthropic are “playing a whole different game,” Ives said.


Fundrise Innovation Fund (NYSE: VCX) to Accelerate Lockup Expiration of Restricted Shares by One Month

The Fundrise Innovation Fund (NYSE: VCX) today announced that the expiration date of the Fund's post-listing share lockup will be adjusted forward by one month, from September 14th, 2026, to August 13th, 2026, which will result in previously locked-up shares being eligible to begin trading on...

OpenAI Faces Another Blow On Road To IPO: Ailment Forces AGI Chief Fidji Simo To Leave After Less Than A Year

OpenAI has seen a string of high-profile departures in recent months, including Chief Product Officer Kevin Weil and Vice President of Engineering Srinivas Narayanan.


OpenAI Returns To The Ring As Anthropic’s Cheaper AI Raises The Stakes – Elon Musk Teases Grok 4.5 

OpenAI announced the GPT-5.6 flagship model, Sol, after delaying its release last month at the U.S. government's request due to security concerns and testing.


Anthropic Takes First Step Toward In-House AI Chip — Talks With Samsung Underway, Says Report

Artificial intelligence startup Anthropic is in preliminary discussions with Samsung Electronics to manufacture its first in-house server chip as it seeks greater control over its computing infrastructure and skyrocketing costs.

Anthropic Clears Major IPO Hurdle As US Lifts Export Controls On Claude AI Fable, Mythos Models

Anthropic withdrew its AI models earlier in June after the U.S. government flagged security vulnerabilities and the potential for their use in harmful activities.


Anthropic Faces More Scrutiny Ahead Of IPO: JPMorgan Reportedly  Follows Goldman In Cutting Claude Access For Hong Kong Staff

Anthropic’s licensing terms prompted the removal of Claude from an internal list of approved large language models available to employees, The Financial Times reported.


Anthropic, OpenAI IPO Watch: AI Chiefs Sam Altman, Dario Amodei, Others Reportedly Join Trump At G7 Summit

CNBC reported that Salesforce CEO Marc Benioff and Meta Platforms’ AI chief Alex Wang will also be attending a meeting on the last day of the summit.


This account has been verified as an official VCX representative.

Verified Account

VCXOfficial

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Neutral Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

VCX Fundrise Innovation Fund